Free Trial

T2 Biosystems (TTOO) Competitors

T2 Biosystems logo
$0.45 -0.02 (-3.59%)
(As of 10:02 AM ET)

TTOO vs. XAIR, SURG, POCI, CODX, ALUR, BSGM, DRIO, IRIX, STIM, and NXGL

Should you be buying T2 Biosystems stock or one of its competitors? The main competitors of T2 Biosystems include Beyond Air (XAIR), SurgePays (SURG), Precision Optics (POCI), Co-Diagnostics (CODX), Allurion Technologies (ALUR), BioSig Technologies (BSGM), DarioHealth (DRIO), IRIDEX (IRIX), Neuronetics (STIM), and NEXGEL (NXGL). These companies are all part of the "medical equipment" industry.

T2 Biosystems vs.

T2 Biosystems (NASDAQ:TTOO) and Beyond Air (NASDAQ:XAIR) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, community ranking, earnings, valuation, profitability, dividends, media sentiment and institutional ownership.

23.2% of T2 Biosystems shares are owned by institutional investors. Comparatively, 31.5% of Beyond Air shares are owned by institutional investors. 0.1% of T2 Biosystems shares are owned by insiders. Comparatively, 20.1% of Beyond Air shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

T2 Biosystems has a beta of 0.38, suggesting that its stock price is 62% less volatile than the S&P 500. Comparatively, Beyond Air has a beta of -0.18, suggesting that its stock price is 118% less volatile than the S&P 500.

T2 Biosystems presently has a consensus price target of $5.00, indicating a potential upside of 1,023.09%. Beyond Air has a consensus price target of $3.67, indicating a potential upside of 628.96%. Given T2 Biosystems' higher possible upside, equities research analysts plainly believe T2 Biosystems is more favorable than Beyond Air.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
T2 Biosystems
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Beyond Air
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
3.00

T2 Biosystems has a net margin of -563.16% compared to Beyond Air's net margin of -2,369.17%. T2 Biosystems' return on equity of 0.00% beat Beyond Air's return on equity.

Company Net Margins Return on Equity Return on Assets
T2 Biosystems-563.16% N/A -174.06%
Beyond Air -2,369.17%-227.29%-106.51%

In the previous week, T2 Biosystems and T2 Biosystems both had 5 articles in the media. Beyond Air's average media sentiment score of 0.55 beat T2 Biosystems' score of 0.50 indicating that Beyond Air is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
T2 Biosystems
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Beyond Air
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

T2 Biosystems received 358 more outperform votes than Beyond Air when rated by MarketBeat users. However, 69.57% of users gave Beyond Air an outperform vote while only 64.44% of users gave T2 Biosystems an outperform vote.

CompanyUnderperformOutperform
T2 BiosystemsOutperform Votes
406
64.44%
Underperform Votes
224
35.56%
Beyond AirOutperform Votes
48
69.57%
Underperform Votes
21
30.43%

T2 Biosystems has higher revenue and earnings than Beyond Air.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
T2 Biosystems$7.19M1.30-$50.08MN/AN/A
Beyond Air$1.16M31.30-$60.24M-$1.41-0.36

Summary

Beyond Air beats T2 Biosystems on 9 of the 16 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TTOO vs. The Competition

MetricT2 BiosystemsSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$9.37M$4.43B$5.07B$8.80B
Dividend YieldN/A36.79%4.99%4.07%
P/E RatioN/A13.5789.5613.60
Price / Sales1.3044.221,224.8087.40
Price / CashN/A52.2739.4536.27
Price / Book-0.805.776.976.33
Net Income-$50.08M$13.76M$119.04M$225.93M
7 Day Performance-14.38%-0.99%-1.78%-0.96%
1 Month Performance-68.87%0.71%-3.59%1.06%
1 Year Performance-88.28%51.46%31.64%26.59%

T2 Biosystems Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TTOO
T2 Biosystems
2.4481 of 5 stars
$0.45
-3.6%
$5.00
+1,023.1%
-88.3%$9.37M$7.19M0.00180
XAIR
Beyond Air
4.2935 of 5 stars
$0.50
+2.3%
$3.67
+629.0%
-69.1%$36.31M$1.16M0.0070Gap Down
SURG
SurgePays
3.787 of 5 stars
$1.72
+17.8%
$9.00
+423.3%
-77.0%$34.68M$137.14M-1.4922
POCI
Precision Optics
0.8663 of 5 stars
$5.35
+0.6%
N/A-11.1%$33.97M$19.10M0.0080
CODX
Co-Diagnostics
4.3727 of 5 stars
$1.04
flat
$1.50
+44.2%
-27.8%$33.21M$6.81M0.00100Short Interest ↓
Gap Down
ALUR
Allurion Technologies
2.7467 of 5 stars
$0.50
+9.1%
$2.88
+475.7%
-88.1%$32.15M$53.47M0.00501Analyst Revision
Gap Up
BSGM
BioSig Technologies
N/A$1.82
-2.7%
N/A-45.1%$31.18M$20,000.000.0050
DRIO
DarioHealth
1.8695 of 5 stars
$0.87
+11.9%
$4.00
+358.2%
-31.6%$29.77M$20.35M-0.93200
IRIX
IRIDEX
0.6933 of 5 stars
$1.74
0.0%
$2.00
+14.9%
-17.1%$28.95M$51.87M0.00120
STIM
Neuronetics
2.3981 of 5 stars
$0.76
-5.0%
$4.67
+512.4%
-40.6%$23.13M$71.35M0.00180
NXGL
NEXGEL
1.4395 of 5 stars
$3.34
+1.2%
N/A+84.4%$22.68M$4.09M0.0010

Related Companies and Tools


This page (NASDAQ:TTOO) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners